PROLIFARON
Prolifaron was developing therapeutic antibodies addressing multiple diseases, including cancer.
PROLIFARON
Industry:
Biopharma Pharmaceutical
Founded:
1997-01-01
Address:
San Diego, California, United States
Country:
United States
Status:
Active
Similar Organizations
August Therapeutics, Inc.
Working to solve complex problems in taste receptor biology and employ new therapeutic modalities to treating eating disorders and obesity.
Sitari Pharmaceuticals
Sitari Pharmaceuticals is a biotechnology company developing treatments for multiple disease indications.
Founder
More informations about "Prolifaron"
Prolifaron - Ownership and Business Overview - Mergr
Sep 25, 2000 Prolifaron is headquartered in San Diego, California. What sector is Prolifaron in? Prolifaron is a life science company. When was Prolifaron founded? Prolifaron was founded in …See details»
Alexion Pharmaceuticals acquires Prolifaron - 2000-09-25
Prolifaron Prolifaron developing therapeutic antibodies addressing multiple diseases, including cancer. Acquiring Organization: Alexion Pharmaceuticals Alexion Pharmaceuticals is a …See details»
Alexion Pharmaceuticals, Inc. FORM 10-Q
Net cash paid in acquisition of Prolifaron — (24) Net cash used in investing activities (3,056) (7,055) CASH FLOWS FROM FINANCING ACTIVITIES: Net proceeds from issuance of …See details»
Alexion Pharmaceuticals Acquires Prolifaron - Mergr
On September 25, 2000, Alexion Pharmaceuticals acquired life science company Prolifaron for 41M USD Acquisition Highlights. This is Alexion Pharmaceuticals’ 1st transaction in the Life …See details»
Alexion Acquires Scripps Spinout Prolifaron For Stock Worth $41M
Sep 26, 2000 Alexion Pharmaceuticals Inc. acquired Prolifaron Inc. through a common stock exchange worth $41 million that should allow Alexion to move products from ground zero to …See details»
Prolifaron - Crunchbase
Prolifaron developing therapeutic antibodies addressing multiple diseases, including cancer.See details»
BioPharmaLink profile of Prolifaron, Inc., United States of America,
Prolifaron is engaged in the discovery and early stage development of novel antibody drug therapies through combinatorial antibody library development, proprietary selection …See details»
Alexion acquires Prolifaron for $41 mill - The Pharma Letter
Sep 24, 2000 Prolifaron, which it is claimed possesses "extensive combinatorial human antibody library technologies and expertise," has been renamed Alexion Antibody Technologies and is …See details»
Acquireprime - Prolifaron, Inc.
Contact Information 3985 Sorrento Valley Boulevard, Suite A San Diego,92121, United StatesSee details»
Prolifaron Trademark - Prolifaron, Llc. - San Diego, CA - Bizapedia
Prolifaron is a Trademark by Prolifaron, LLC., the address on file for this trademark is 11494 Sorrento Valley Road Suite K, San Diego, CA 92121. Trademark Introduction: PROLIFARON …See details»
BioCentury - Prolifaron Inc.
Jan 24, 2000 San Diego, Calif. Technology: Phage display antibody libraries for drug discovery.....See details»
Katherine Bowdish: Positions, Relations and Network
Aug 11, 2020 Prolifaron, Inc. Medical Specialties Health Technology. Part of AstraZeneca PLC, Prolifaron, Inc. is a company that develops antibodies addressing multiple disease areas. The …See details»
Prolifaron L L C Trademarks & Logos - US Patent and Trademark …
Prolifaron, LLC. Trademark Applications. Mark Image. Registration | Serial. Trademark. Application Date "P R O L I F A R O N" 2410340 75773646. P R O L I F A R O N . 1999-08-12 …See details»
Carlos F. Barbas III - Wikipedia
From 1997 to April 2001, Barbas dedicated his efforts in Prolifaron LLC as a co-founder. The main aim of founding this company is to put his research on antibodies into new therapies with the …See details»
Prolifaron | www.inknowvation.com
Prolifaron Profile last edited on: 7/31/2008. NO Business Identifier is currently available for this company. Year Founded 1997. 1st Awd Year 1998. Latest Award 1998. Program Status …See details»
Alexion Pharmaceuticals - Funding, Financials, Valuation & Investors
Which industries has this organization had the most exits in? Show . Moderna Moderna Therapeutics is a biotechnology company that specializes in vaccines and drug development. …See details»
Cross-species comparison reveals that Hmga1 reduces H3K27me3 …
6 days ago Diverse roles for Hmga1-driven chromatin organization and gene regulation have been postulated, showing both activating and repressive effects in different contexts …See details»
9 Best Pro-Life Charities Making a Real Impact - Nonprofit Point
Jun 4, 2023 The organization works with local affiliates and partners in over 100 countries, focusing on grassroots efforts, training, and support for pro-life leaders. HLI promotes the …See details»
North Korea Designations; Non-Proliferation Designations; Russia ...
Dec 16, 2024 Transactions Prohibited For Persons Owned or Controlled By U.S. Financial Institutions: North Korea Sanctions Regulations section 510.214; Organization Established …See details»
The Perils of Proliferation: Organization Theory, Deterrence Theory ...
Organization Theory, Deterrence Theory, and the Spread of Nuclear Weapons An apparent contra-diction lies at the center of our understandings about nuclear weapons and deterrence. …See details»